These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The therapeutic role of dendritic cells in cancer immunotherapy. Lemoli RM; Curti A; Fogli M; Ferri E; Baccarani M Haematologica; 2002 Aug; 87(8 Suppl):62-6. PubMed ID: 12412393 [No Abstract] [Full Text] [Related]
4. Monocyte-derived dendritic cells: a promising armament for immunotherapy in human malignancies. Yi Q; Kwak LW Clin Cancer Res; 2005 Feb; 11(3):966-7. PubMed ID: 15709160 [No Abstract] [Full Text] [Related]
5. Cancer Immunotherapy by coordinated stimulation of innate lymphocytes (NK and NKT cells). Fujii S Rinsho Ketsueki; 2009 May; 50(5):364-74. PubMed ID: 19483396 [No Abstract] [Full Text] [Related]
6. Tumor-dendritic cell fusion technology and immunotherapy strategies. Shu S; Cohen P J Immunother; 2001; 24(2):99-100. PubMed ID: 11265778 [No Abstract] [Full Text] [Related]
7. Dendritic cells in the treatment of cancer. Engleman EG Biol Blood Marrow Transplant; 1996 Oct; 2(3):115-7. PubMed ID: 9199753 [No Abstract] [Full Text] [Related]
8. Cancer therapy-induced immune modulation. Karl JC; Mackall CL Cancer Chemother Biol Response Modif; 2005; 22():325-41. PubMed ID: 16110619 [No Abstract] [Full Text] [Related]
16. The use of dendritic cells in cancer immunotherapy. Nencioni A; Grünebach F; Schmidt SM; Müller MR; Boy D; Patrone F; Ballestrero A; Brossart P Crit Rev Oncol Hematol; 2008 Mar; 65(3):191-9. PubMed ID: 18055210 [TBL] [Abstract][Full Text] [Related]
17. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Tacken PJ; de Vries IJ; Torensma R; Figdor CG Nat Rev Immunol; 2007 Oct; 7(10):790-802. PubMed ID: 17853902 [TBL] [Abstract][Full Text] [Related]
18. Potential applications for plasmacytoid dendritic cells in cancer immunotherapy. Tel J; de Vries IJ Immunotherapy; 2012 Oct; 4(10):979-82. PubMed ID: 23148748 [No Abstract] [Full Text] [Related]